← peptides typeshit

Rezera's ruvonoflast adds anti-inflammatory effect to semaglutide in Phase 2

Rezera says its drug ruvonoflast, taken alongside semaglutide, gave an extra anti-inflammatory benefit in the RESOLVE-2 trial.

Read at Dealroom

Recap by typeshit. Full story at Dealroom.